Turning off a few overexpressed genes in prostate cancer with microRNAs using a 7mer-seed match model

Arpita Purkayastha1, Aparajita Roy1, Stella Bharadaj2

  • 1Department of Biotechnology, Assam University, Silchar, Assam, 788011, India.

Abstract

Insights

Researchers identified microRNAs targeting genes overexpressed in prostate cancer. These microRNAs show potential for developing novel miRNA-based therapeutics to silence cancer-promoting genes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Prostate cancer is characterized by the overexpression of specific genes.
  • MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various cancers.
  • Targeting overexpressed genes with miRNAs offers a potential therapeutic strategy.

Purpose of the Study:

  • To identify specific human microRNAs capable of targeting genes overexpressed in prostate cancer.
  • To lay the groundwork for developing novel miRNA-based therapeutics for prostate cancer treatment.

Main Methods:

  • Utilized a 7mer-m8 model to analyze miRNA-gene interactions.
  • Evaluated miRNA binding efficiency using parameters like free energy, GC content, translation efficiency, and mRNA stability.
  • Employed BLAST2GO software for functional elucidation of prostate cancer-associated genes.

Main Results:

  • Multiple miRNAs were found to target the coding sequences of overexpressed prostate cancer genes.
  • The HPN gene was identified as a target for miR-4279 at two distinct sites.
  • Target regions showed higher GC and GC3 content compared to flanking regions, with low translational rates possibly due to suboptimal codons.

Conclusions:

  • Successfully identified human miRNAs with the potential to bind and silence the coding sequences of 14 highly overexpressed genes in prostate cancer.
  • These findings provide a foundation for future development of miRNA-based therapies targeting prostate cancer.